Noxopharm Ltd
Noxopharm Limited, a biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia. It develops Sofra, a platform that focuses on the development of immunomodulators for mRNA vaccines and mRNA therapeutics, as well as for the treatment of autoimmune diseases; and Chroma technology platform to develop CRO-67 dual-cell therapy drug… Read more
Noxopharm Ltd (NOX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -6.614x
Based on the latest financial reports, Noxopharm Ltd (NOX) has a cash flow conversion efficiency ratio of -6.614x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.56 Million) by net assets (AU$689.96K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Noxopharm Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Noxopharm Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Noxopharm Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Noxopharm Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Scorpion Minerals Ltd
AU:SCN
|
-0.239x |
|
PT Hatten Bali Tbk
JK:WINE
|
0.060x |
|
Reborn Coffee Inc
NASDAQ:REBN
|
0.474x |
|
Ackerstein Group Ltd
TA:ACKR
|
0.003x |
|
Kalamazoo Resources Limited
PINK:KAMRF
|
-0.024x |
|
Boston Sand & Gravel Co
PINK:BSND
|
N/A |
|
New York City REIT Inc
NYSE:NYC
|
0.011x |
|
Sahathai Printing & Packaging PCL
BK:STP
|
0.073x |
Annual Cash Flow Conversion Efficiency for Noxopharm Ltd (2016–2025)
The table below shows the annual cash flow conversion efficiency of Noxopharm Ltd from 2016 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$689.96K | AU$-5.82 Million | -8.442x | -6679.01% |
| 2024-06-30 | AU$5.50 Million | AU$-684.31K | -0.125x | +89.68% |
| 2023-06-30 | AU$9.07 Million | AU$-10.95 Million | -1.206x | -111.87% |
| 2022-06-30 | AU$24.12 Million | AU$-13.73 Million | -0.569x | -162.35% |
| 2021-06-30 | AU$40.78 Million | AU$-8.85 Million | -0.217x | +74.91% |
| 2020-06-30 | AU$12.87 Million | AU$-11.14 Million | -0.865x | -112.84% |
| 2019-06-30 | AU$-1.45 Million | AU$-9.78 Million | 6.740x | +853.61% |
| 2018-06-30 | AU$10.15 Million | AU$-9.08 Million | -0.894x | +24.37% |
| 2017-06-30 | AU$2.47 Million | AU$-2.92 Million | -1.183x | -1179.11% |
| 2016-06-30 | AU$5.95 Million | AU$-549.72K | -0.092x | -- |